Moneycontrol
HomeNewsIndiaCoronavirus pandemic | No job, salary cuts so far but can't say about future, says HUL
Trending Topics

Coronavirus pandemic | No job, salary cuts so far but can't say about future, says HUL

Addressing a media conference call on the company's quarterly earnings, Mehta said Hindustan Unilever (HUL) has already taken various cost saving measures but steps for the road ahead will depend on how the economy behaves after the country emerges from the health crisis.

April 30, 2020 / 21:15 IST
Story continues below Advertisement

FMCG major Hindustan Unilever CMD Sanjiv Mehta on Thursday said the company has not cut any jobs or salary of employees so far due to the coronavirus pandemic but cannot say what will happen in future.

Addressing a media conference call on the company's quarterly earnings, Mehta said Hindustan Unilever (HUL) has already taken various cost saving measures but steps for the road ahead will depend on how the economy behaves after the country emerges from the health crisis.

Story continues below Advertisement

"Right now we have not shed any jobs and at this stage we have not done any salary cuts, but I would not be able to say what is going to happen in the future because we will have to see how the situation evolves," he said.

Coronavirus India LIVE Updates

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show